Literature DB >> 17515584

Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial.

Anne Holbrook1, Renée Labiris, Charles H Goldsmith, Kaede Ota, Sandra Harb, Rolf J Sebaldt.   

Abstract

BACKGROUND: Decision aids have been shown to be useful in selected situations to assist patients in making treatment decisions. Important features such as the format of decision aids and their graphic presentation of data on benefits and harms of treatment options have not been well studied.
METHODS: In a randomized trial with a 3 x 2 factorial design, we investigated the effects of decision aid format (decision board, decision booklet with audiotape, or interactive computer program) and graphic presentation of data (pie graph or pictogram) on patients' comprehension and choices of 3 treatments for anticoagulation, identified initially as "treatment A" (warfarin), "treatment B" (acetylsalicylic acid) and "treatment C" (no treatment). Patients aged 65 years or older without known atrial fibrillation and not currently taking warfarin were included. The effect of blinding to the treatment name was tested in a before-after comparison. The primary outcome was change in comprehension score, as assessed by the Atrial Fibrillation Information Questionnaire. Secondary outcomes were treatment choice, level of satisfaction with the decision aid, and decisional conflict.
RESULTS: Of 102 eligible patients, 98 completed the study. Comprehension scores (maximum score 10) increased by an absolute mean of 3.1 (p < 0.01) after exposure to the decision aid regardless of the format or graphic presentation. Overall, 96% of the participants felt that the decision aid helped them make their treatment choice. Unblinding of the treatment name resulted in 36% of the participants changing their initial choice (p < 0.001).
INTERPRETATION: The decision aid led to significant improvement in patients' knowledge regardless of the format or graphic representation of data. Revealing the name of the treatment options led to significant shifts in declared treatment preferences.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17515584      PMCID: PMC1867833          DOI: 10.1503/cmaj.060837

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  42 in total

Review 1.  Antithrombotic therapy in atrial fibrillation.

Authors:  G W Albers; J E Dalen; A Laupacis; W J Manning; P Petersen; D E Singer
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.

Authors:  T J Bungard; W A Ghali; F A McAlister; A M Buchan; A J Cave; P G Hamilton; L B Mitchell; A Shuaib; K K Teo; R T Tsuyuki
Journal:  CMAJ       Date:  2001-08-07       Impact factor: 8.262

3.  The effect of decision aids on the agreement between women's and physicians' decisional conflict about hormone replacement therapy.

Authors:  France Légaré; Annette M O'Connor; Ian D Graham; Georges A Wells; Mary Jane Jacobsen; Tom Elmslie; Elizabeth R Drake
Journal:  Patient Educ Couns       Date:  2003-06

4.  The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation.

Authors:  Tammy J Bungard; William A Ghali; Finlay A McAlister; Alastair M Buchan; Andrew J Cave; Peter G Hamilton; L Brent Mitchell; Ashfaq Shuaib; Koon K Teo; Ross T Tsuyuki
Journal:  Can J Cardiol       Date:  2003-03-15       Impact factor: 5.223

Review 5.  Health decision aids to facilitate shared decision making in office practice.

Authors:  Michael J Barry
Journal:  Ann Intern Med       Date:  2002-01-15       Impact factor: 25.391

6.  Randomised controlled trial of an interactive multimedia decision aid on benign prostatic hypertrophy in primary care.

Authors:  E Murray; H Davis; S S Tai; A Coulter; A Gray; A Haines
Journal:  BMJ       Date:  2001-09-01

Review 7.  Variability in patient preferences for participating in medical decision making: implication for the use of decision support tools.

Authors:  A Robinson; R Thomson
Journal:  Qual Health Care       Date:  2001-09

8.  Randomised controlled trial of an interactive multimedia decision aid on hormone replacement therapy in primary care.

Authors:  E Murray; H Davis; S S Tai; A Coulter; A Gray; A Haines
Journal:  BMJ       Date:  2001-09-01

9.  Is information always a good thing? Helping patients make "good" decisions.

Authors:  Peter A Ubel
Journal:  Med Care       Date:  2002-09       Impact factor: 2.983

Review 10.  Decision aids for people facing health treatment or screening decisions.

Authors:  A M O'Connor; D Stacey; V Entwistle; H Llewellyn-Thomas; D Rovner; M Holmes-Rovner; V Tait; J Tetroe; V Fiset; M Barry; J Jones
Journal:  Cochrane Database Syst Rev       Date:  2003
View more
  19 in total

Review 1.  Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Samantha MacLean; Sohail Mulla; Elie A Akl; Milosz Jankowski; Per Olav Vandvik; Shanil Ebrahim; Shelley McLeod; Neera Bhatnagar; Gordon H Guyatt
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Using decision aids to help patients navigate the "grey zone" of medical decision-making.

Authors:  Annette M O'Connor
Journal:  CMAJ       Date:  2007-05-22       Impact factor: 8.262

3.  Patient preferences regarding atrial fibrillation stroke prophylaxis in patients at potential risk of atrial fibrillation.

Authors:  Nicholas T Edwards; Erica D Greanya; Peter S Loewen; Celia L Culley
Journal:  Int J Clin Pharm       Date:  2017-03-09

4.  Constructing a relevant decision aid for parents of children with bronchopulmonary dysplasia.

Authors:  M Skibo; U Guillen; H Zhang; D Munson; A Mackley; K Nilan; H Kirpalani
Journal:  J Perinatol       Date:  2017-10-19       Impact factor: 2.521

Review 5.  Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.

Authors:  Danielle E Clarkesmith; Helen M Pattison; Phyo H Khaing; Deirdre A Lane
Journal:  Cochrane Database Syst Rev       Date:  2017-04-05

6.  Optimizing the use of oral anticoagulant therapy for atrial fibrilation in primary care: a pharmacist-led intervention.

Authors:  Mandeep S Virdee; Derek Stewart
Journal:  Int J Clin Pharm       Date:  2017-01-03

7.  Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives.

Authors:  Pablo Alonso-Coello; Victor M Montori; M Gloria Díaz; Philip J Devereaux; Gemma Mas; Ana I Diez; Ivan Solà; Mercè Roura; Juan C Souto; Sven Oliver; Rafael Ruiz; Blanca Coll-Vinent; Ignasi Gich; Holger J Schünemann; Gordon Guyatt
Journal:  Health Expect       Date:  2014-05-12       Impact factor: 3.377

8.  Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.

Authors:  Patrick P Kneeland; Margaret C Fang
Journal:  Patient Prefer Adherence       Date:  2010-03-24       Impact factor: 2.711

9.  Evaluation of a pharmacist-led shared decision-making in atrial fibrillation and patients' satisfaction-a before and after pilot study.

Authors:  Viviane Khalil; Samantha Blackley; Ashwin Subramaniam
Journal:  Ir J Med Sci       Date:  2020-08-17       Impact factor: 1.568

10.  Preferences for oral anticoagulants in atrial fibrillation: a best-best discrete choice experiment.

Authors:  Peter Ghijben; Emily Lancsar; Silva Zavarsek
Journal:  Pharmacoeconomics       Date:  2014-11       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.